CNTA
Centessa Pharmaceuticals plc
NASDAQ · Healthcare · Biotechnology · GB
$40.50
+0.00%Leverage
- Debt / equity
- 0.02x
- Net debt / equity
- -0.11x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.03x
- Net debt / EBITDA
- 0.21x
Liquidity & coverage
- Current ratio
- 9.53x
- Quick ratio
- 9.53x
- Cash ratio
- 7.56x
- Interest coverage
- -22.70x
- EBITDA / interest
- -23.04x
- Working capital
- $312.1M
Cash & dividend
- FCF / debt
- -28.37x
- Cash flow / debt
- -28.32x
- Dividend per share
- $38
- Dividend yield
- 93.8%
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026